CAPSTONE HOLDING CORP. ANNOUNCES CHANGE OF EQUITY OWNERSHIP IN DIAMOND PRODUCTS HOLDING, LLC
November 21, 2023
by Barbara Dunford
Comments Off on Press Release November 21, 2023
November 21, 2023
by Barbara Dunford
Comments Off on Press Release November 21, 2023
CAPSTONE HOLDING CORP. ANNOUNCES CHANGE OF EQUITY OWNERSHIP IN DIAMOND PRODUCTS HOLDING, LLC
August 29, 2023
by Barbara Dunford
Comments Off on Press Release August 28, 2023
Capstone Holding Corp. Announces CFO Change
March 30, 2023
by Barbara Dunford
Comments Off on Press Release March 7, 2023
Capstone Therapeutics Corp. Announces Results of Annual Meeting
June 21, 2022
by Barbara Dunford
Comments Off on Press Release June 21, 2022
CAPSTONE HOLDING CORP. ANNOUNCES EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION BY MAJORITY SHAREHOLDER, BP PEPTIDES, LLC
December 2, 2021
by Barbara Dunford
Comments Off on Press Release December 2, 2021
CAPSTONE THERAPEUTICS CORP. ANNOUNCES RESULTS OF ANNUAL MEETING
November 12, 2021
by Barbara Dunford
Comments Off on Press release November 12, 2021
The Annual Meeting of Stockholders of Capstone Therapeutics Corp. will be held on Thursday, December 1, 2021
April 14, 2021
by Barbara Dunford
Comments Off on Press Release April 6, 2021
CAPSTONE THERAPEUTICS CORP. ANNOUNCES TRANSACTION WITH DIAMOND PRODUCTS HOLDINGS, LLC
March 31, 2021
by Barbara Dunford
Comments Off on Press Release March 31, 2020
CAPSTONE THERAPEUTICS ANNOUNCES OPERATING RESULTS FOR FISCAL 2020 – INCLUDING A CHANGE IN ITS DEFERRED TAX VALUATION ALLOWANCE
February 18, 2021
by Barbara Dunford
Comments Off on Press Release February 18, 2021
CAPSTONE THERAPEUTICS ANNOUNCES RESULTS OF SPECIAL SHAREHOLDER MEETING, AND A LICENSE TRANSFER/ROYALTY AGREEMENT AND EXIT FROM THE PHARMACEUTICAL DEVELOPMENT BUSINESS
December 28, 2020
by Barbara Dunford
Comments Off on Press Release December 28, 2020
Capstone Therapeutics Announces Exercise of Secured Debt and Interest Conversion Option by BP Peptides, LLC and Change in Control